Home › Janssen announces acquisition of XO1
 

Keywords :   


Janssen announces acquisition of XO1

2015-03-19 17:25:24| Biotech - Topix.net

Janssen Pharmaceuticals, Inc. , one of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced today that it has acquired XO1 Limited, a privately held asset-centric virtual biopharmaceutical company founded to develop the anti-thrombin antibody ichorcumab. Financial terms of the transaction have not been disclosed.

Tags: acquisition announces janssen announces acquisition

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
26.06Eastern North Pacific Tropical Weather Outlook
26.06Atlantic Tropical Weather Outlook
26.06Aer Lingus pilots begin industrial action over pay dispute
25.06Water requirements in the summer
25.06New model Is transforming the study of liver abscesses in cattle
25.06Royal Mail buyer to make offer for all staff shares
25.06World's biggest music labels sue over AI copyright
25.06Hybrid Software wins FLAG Vendor Partner of the Year award
More »